AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Pediatric cancer, while rare, is a devastating diagnosis that is estimated to affect over 11,000 children in the United...
As we welcome the fall season, it’s time for our September edition of Editors’ Picks, a monthly collection of...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved wrapped...
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
The injustices come in many ways. A transgender woman is admitted to the hospital for cancer treatment. Her physicians...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved kicked...
Immunotherapy is a form of cancer treatment that helps a patient’s own immune system recognize and attack cancer cells....
Today, the American Association for Cancer Research (AACR) released its ninth annual Cancer Progress Report. The report highlights how...
Cancer researchers often focus on developing novel treatments or combining therapies in new ways, all with the goal of...